Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest Amyotrophic lateral sclerosis Stories

2014-02-06 08:29:41

Live Webcast to Air on Tuesday, February 11, at 3:00 p.m. EST ROCKVILLE, Md., Feb. 6, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that President and CEO Richard Garr will present at the 16(th) Annual BIO CEO & Investor Conference 2014 in New York City on Tuesday, February 11, at 3:00 p.m. EST. Garr will present clinical updates on the company's 2014 NSI-566 cell therapy trials program, including ongoing ALS Phase II; ALS Phase II in Mexico City;...

2014-02-05 23:03:02

A study led by St. Jude Children’s Research Hospital offers a new avenue for scientists to pursue in the quest for desperately needed treatments for ALS Memphis, Tenn. (PRWEB) February 05, 2014 St. Jude Children’s Research Hospital scientists led a study showing that mutations in a gene responsible for amyotrophic lateral sclerosis (ALS) disrupt the RNA transport system in nerve cells. The findings appear in the current issue of the scientific journal Neuron and offer a new focus for...

Genetic Makeup Determines Parkinson's Risk From Pesticide Use
2014-02-05 09:34:22

Rebekah Eliason for redOrbit.com – Your Universe Online In the past, studies have shown that pesticides can cause an increased risk for the development of Parkinson’s disease. Recently, UCLA researchers have discovered that amount of risk varies with a person’s individual genetic makeup. People with a specific genetic variant and are living in extreme pesticide-exposed areas have an increased likelihood of developing the disease by two- to six-fold. Previously, the UCLA team found...

2014-02-04 12:27:49

WASHINGTON, Feb. 4, 2014 /PRNewswire-USNewswire/ -- The ALS Association is pleased to announce the awarding of five new grants to investigate the causes and treatment of ALS. The ALS Association identified the focus of each of these grants as areas with high potential for progress. (Logo: http://photos.prnewswire.com/prnh/20131211/MM32178LOGO) ALS, which is also known as Lou Gehrig's Disease, is a progressive neurodegenerative disease that affects nerve cells in the brain and the...

2014-01-30 23:02:50

PatientsLikeMe Co-Founder Jamie Heywood to Kick Off Conference Horsham, PA (PRWEB) January 30, 2014 Jamie Heywood, patient engagement and research pioneer, will deliver the keynote address at the DIA 2014 50th Annual Meeting, to be held June 15–19 at the San Diego Convention Center. Heywood is co-founder of PatientsLikeMe, a groundbreaking online platform where hundreds of thousands of patients connect with one another to track their experiences with diseases, share details of their...

2014-01-30 12:28:16

TUCSON, Ariz. and CAMBRIDGE, Mass., Jan. 30, 2014 /PRNewswire-USNewswire/ -- The Muscular Dystrophy Association (MDA) and Augie Nieto, co-chairman of MDA's ALS division, together with his wife, Lynne, today announced they are transitioning management of the successful "Augie's Quest" campaign from MDA to the ALS Therapy Development Institute (ALS TDI). The transition will be occurring in the first quarter of 2014 as the two organizations continue to support Augie's Quest initiatives....

2014-01-28 09:12:25

Kennedy Krieger researchers develop valid and accurate model for FSHD Researchers at the Kennedy Krieger Institute recently announced study findings showing the successful development of a humanized preclinical model for facioscapulohumeral muscular dystrophy (FSHD), providing scientists with a much needed tool to accelerate novel therapeutic research and development. Published in Human Molecular Genetics, the study outlines the validity of a unique model that, for the first time,...

2014-01-24 11:40:44

Using a novel high-throughput screening process, scientists have for the first time identified molecules with the potential to block the accumulation of a toxic eye protein that can lead to early onset of glaucoma. Glaucoma is a group of diseases that can damage the eye’s optic nerve and cause vision loss and blindness. Elevated eye pressure is the main risk factor for optic nerve damage. Researchers have implicated a mutant form of a protein called myocilin as a possible root cause...

Concussed Girls Playing Soccer
2014-01-21 11:51:47

Brett Smith for redOrbit.com - Your Universe Online A new study on young female soccer players came to a worrying conclusion: many of them continue to play after suffering a concussion on the pitch. Conducted by researchers in Washington State, the study looked at the incidence and length of concussions in young female soccer players between the ages of 11 and 14, as well as whether symptoms resulted in them coming off the soccer pitch and seeking medical treatment. Concussion symptoms...

2014-01-16 23:31:02

Cellular Life Research Center has awarded it's Advanced Research Recognition award to PIMTforLife. In clinical trials, patients taking PIMTforLife, an all-natural anti-aging tablet, have shown a dramatic reverse in signs of aging in as little time as three weeks. St. Petersburg, FL (PRWEB) January 16, 2014 PIMTforLife is the number one anti-aging tablet recognized by the Cellular Life Research Center for its unique and highly effective utilization of the PIMT enzyme and is also now...